BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10559508)

  • 1. HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease.
    Järvisalo MJ; Toikka JO; Vasankari T; Mikkola J; Viikari JS; Hartiala JJ; Raitakari OT
    Atherosclerosis; 1999 Dec; 147(2):237-42. PubMed ID: 10559508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients.
    Egede R; Jensen LO; Hansen HS; Antonsen L; Hansen KN; Junker A; Thayssen P
    Int J Cardiol; 2012 Jul; 158(3):376-9. PubMed ID: 21349594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Chikamori T; Sugimoto K; Hamada T; Kitaoka H; Furuno T; Seo H; Doi Y
    J Cardiol; 2000 Feb; 35(2):95-101. PubMed ID: 10713930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.
    Rosenson RS
    Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy improves brachial artery endothelial function in nephrotic syndrome.
    Dogra GK; Watts GF; Herrmann S; Thomas MA; Irish AB
    Kidney Int; 2002 Aug; 62(2):550-7. PubMed ID: 12110017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.
    Balletshofer BM; Goebbel S; Rittig K; Enderle M; Schmölzer I; Wascher TC; Ferenc Pap A; Westermeier T; Petzinna D; Matthaei S; Häring HU
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):324-30. PubMed ID: 15977099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
    Hamilton SJ; Chew GT; Davis TM; Watts GF
    Clin Sci (Lond); 2010 Feb; 118(10):607-15. PubMed ID: 20047560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hypertriglyceridemia on endothelial dysfunction during statin ± ezetimibe therapy in patients with coronary heart disease.
    Yunoki K; Nakamura K; Miyoshi T; Enko K; Kubo M; Murakami M; Hata Y; Kohno K; Morita H; Kusano KF; Ito H
    Am J Cardiol; 2011 Aug; 108(3):333-9. PubMed ID: 21545981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching to aggressive statin improves vascular endothelial function in patients with stable coronary artery disease.
    Hoshiga M; Arishiro K; Nakakoji T; Miyazaki N; Negoro N; Okabe T; Kohbayashi E; Ishihara T; Hanafusa T
    J Atheroscler Thromb; 2010 Jul; 17(7):705-11. PubMed ID: 20065610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Effect of Statin Therapy at a High Dose Versus Low Dose Associated with Ezetimibe.
    Garcia MM; Varela CG; Silva PF; Lima PR; Góes PM; Rodrigues MG; Silva Mde L; Ladeia AM; Guimarães AC; Correia LC
    Arq Bras Cardiol; 2016 Apr; 106(4):279-88. PubMed ID: 27142792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
    Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
    Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term changes of flow-mediated vasodilation in patients under statin therapy.
    Frick M; Alber HF; Hügel H; Schwarzacher SP; Pachinger O; Weidinger F
    Clin Cardiol; 2002 Jun; 25(6):291-4. PubMed ID: 12058793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial nitric oxide synthase.
    Chen H; Ren JY; Xing Y; Zhang WL; Liu X; Wu P; Wang RJ; Luo Y
    Int J Cardiol; 2009 Jan; 131(3):313-20. PubMed ID: 18221806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial).
    Dupuis J; Tardif JC; Rouleau JL; Ricci J; Arnold M; Lonn E; Roux R; Title LM; Amyot R; Bonafede N; Woo A; Cannon CP
    Am J Cardiol; 2005 Nov; 96(9):1207-13. PubMed ID: 16253583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors].
    Chen H; Ren JY; Wu B; Liu X; Wang RJ; Li LJ; Luo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):531-5. PubMed ID: 17711713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography.
    Callister TQ; Raggi P; Cooil B; Lippolis NJ; Russo DJ
    N Engl J Med; 1998 Dec; 339(27):1972-8. PubMed ID: 9869668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictors of abnormal arterial function in statin-treated type 2 diabetes mellitus patients.
    Hamilton SJ; Chew GT; Davis TM; Watts GF
    Metabolism; 2012 Mar; 61(3):349-57. PubMed ID: 21944268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous testosterone and brachial artery endothelial function in middle-aged men with symptoms of late-onset hypogonadism.
    Mäkinen JI; Perheentupa A; Irjala K; Pöllänen P; Mäkinen J; Huhtaniemi I; Raitakari OT
    Aging Male; 2011 Dec; 14(4):237-42. PubMed ID: 21831030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.